Back

Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation.

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: basic science - epidemiology Pathophysiology and Mechanisms EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Magdalena Klis

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
A novel score predictor for atrial fibrillation in cardiac implantable electronic device patients
Doctor S. Jaroonpipatkul (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Postoperative atrial fibrillation is associated with late mortality independently of patient comorbidities: a systematic review and reconstructed individual patient data meta-analysis.
Mr M. Kawczynski (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Investigating the relationship between the leukocyte telomere length and the incidence of atrial fibrillation: a study utilizing data from the UK Biobank
Doctor H. Kim (Ulsan, KR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation is perpetuated by human heart secretome in ex-vivo langendorff-perfused hearts.
Associate Professor F. Hohendanner (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Secondhand tobacco smoke and risk of atrial fibrillation: an observational epidemiologic and gene-environment interaction analysis
Doctor K. Lee (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: basic science - epidemiology

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Left atrial morpho-functional parameters and their correlation with other phenotypic and functional characteristics of hypertrophic cardiomyopathy.
thumbnail
Congress Presentation
Long-term efficacy and safety of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Effect of catheter ablation vs medical therapy on cardiovascular outcomes in hypertrophic cardiomyopathy with atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources